An Example of
Pathology-Model Based Target Validation
Background: An in vitro study
had suggested that molecule X secreted by tumor cells might induce T
cell apoptosis, so as to help tumor cells escape from T cell mediated
tumor cell killing. The purpose of the profiling project was to
find evidence supporting this suggestion and to evaluate
suitability of the molecule as a target for antibody
therapeutics.
Procedures
Results
Picture
Antibody production
Specific antibody was produced.
The antibody recognized a single band
with correct molecular weight in Western blot (as indicated by
the arrow).
IHC tissue profiling was performed
in standard normal tissue arrays.
IHC tissue profiling showed a
dominant cytoplasmic staining pattern of the molecule in a wide
range of organs of the human body.
IHC tissue profiling was performed
in standard tumor tissue arrays.
IHC tissue profiling showed
slightly higher than normal expression levels of the molecule in a wide
range of tumors.
IHC (left) and TUNEL (right)
analyses to correlate apoptic index with expression levels of
the molecule in our apoptosis related model.
High expression level of the
molecule (left top brown staining indicated by the arrow) did not correlate with the apoptotic index
in the model. The brown dots on the right indicated by arrows
are apoptotic bodies.
IHC detection of CD4 and CD8
populations in the apoptosis model.
There were abundant CD4 and CD8
lymphocytes (indicated by arrows) near or within the tumor cells that showed high
level of molecule X.
Pharmacological aspect
IHC showed high expression levels of the
molecule in many vital organs. The arrows indicate strong
staining in the
tubular epithelial cells of the kidney.
Conclusion
Our pathology model-based analyses did not
support the original hypothesis that molecule X might induce T cell
apoptosis. The high expression levels of the molecule found in
many vital organs indicate that the molecule is not suitable as
a target for antibody therapeutics.